| HOME >> BIOLOGY >> TECHNOLOGY |
NEW YORK, May 13 /PRNewswire/ -- Johnson & Johnson today announced that Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder N. Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London have been named the recipients of the 2008 Dr. Paul Janssen Award for Biomedical Research by an independent selection committee of world-renowned scientists.
The award salutes the most passionate and creative scientists in basic or clinical research, whose scientific achievements have made, or have strong potential to make, a measurable impact on human health. Feldmann and Maini were selected for their role in the discovery of tumor necrosis factor-alpha, or TNF-alpha, as an effective therapeutic target for rheumatoid arthritis and other chronic inflammatory conditions afflicting millions worldwide. The award, which includes a $100,000 prize, will be presented to the winners at events in New York and Beerse, Belgium in September.
According to Solomon Snyder, Ph.D., Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry, Johns Hopkins School of Medicine and Chairman, Janssen Award Selection Committee, "The work of Feldmann and Maini exemplifies the bench-to-bedside approach that Paul Janssen's contributions epitomized. It is extremely rare for researchers to identify a molecular messenger in test tube studies, demonstrate its physiologic relevance in animals and themselves carry these efforts forward to a successful clinical demonstration. Feldmann and Maini did all of this, leading to therapeutic agents of inestimable, lifesaving importance."
Established by Johnson & Johnson, the Dr. Paul Janssen Award for
Biomedical Research honors the founder of Janssen Pharmaceutica. Known to
his colleagues as "Dr. Paul," Janssen was one of the 20th century's most
gifted and passionate researchers, a physician-scientist who helped save
millions of lives through his contribution to the disc
'/>"/>
| SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
2. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
3. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
4. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
5. Black Box Network Services, ABTECH, Verizon Business and Wyle Named Top Siemens Reseller Partners
6. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
7. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
8. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
9. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
10. Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
11. Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |